IBS Days 2026: from pathophysiology to microbiome modulation
The 2026 IBS Days conference in Bologna explored the latest research on Irritable Bowel Syndrome, focusing on the gut microbiome and non-pharmacological treatments. Experts discussed the overlap between IBS and other conditions like IBD and endometriosis.
Why it matters
Advancements in understanding gut health are critical for improving diagnostic accuracy and quality of life for millions suffering from chronic gastrointestinal disorders.
The fifth edition of IBS Days delved into the latest developments in IBS research and clinical management. This article aims to explore causes that can be misdiagnosed as IBS and non-pharmacological strategies targeting gut barrier and gut microbiome dysfunction.
From 15 to 17 June 2026, Gut Microbiota for Health attended IBS Days in Bologna, Italy, which celebrated its 10 th anniversary. Sessions at the conference cross-cut basic, translational, and clinical science in IBS, including epidemiology, genetic influences, gut microbiota, immune pathways, dietary and infectious triggers, biomarker advances, and non-pharmacological interventions.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in